Bluebird Bio Inc. buy Barclays PLC
Start price
15.08.24
/
50%
€0.70
Target price
15.08.25
€3.64
Performance (%)
-47.73%
End price
16.08.25
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC for Bluebird Bio Inc. is performing very badly with a performance of -47.73%. Barclays_PLC has a follow-up prediction for Bluebird Bio Inc. where he still thinks Bluebird Bio Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $8.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten